(Press-News.org) Quick facts: Clinical research, 752 individuals with type 2 diabetes, quantitative study, DNA methylation as a way to identify epigenetic biomarkers in blood.
People with type 2 diabetes are up to four times more likely to have heart attacks, strokes, anginas and other coronary heart diseases than healthy people. Therefore, biomarkers that help us understand which individuals are at risk of being affected are needed.
A research team led from Lund University in Sweden, followed 752 people who, when the study started, were newly diagnosed with type 2 diabetes. None of the participants, who came from the diabetes cohort ANDIS (All New Diabetics in Skåne), had previously had any major cardiovascular diseases. The researchers followed the participants' cardiovascular health for just over seven years, during which time 102 of them suffered serious cardiovascular complications.
"By studying chemical changes in the participants' genome – so-called DNA methylation – we wanted to find epigenetic biomarkers that predict cardiovascular disease. DNA methylation controls which genes are active or turned off in our cells, and when it does not work properly, it can contribute to the development of cardiovascular disease", says Charlotte Ling, Professor of Diabetes research at Lund University.
The researchers found more than 400 sites with altered DNA methylation in blood and 87 of these were used to develop a score scale that can assess an individual's risk of developing serious cardiovascular complications.
"We could say with a 96 percent probability whether someone was not at risk of developing cardiovascular disease. The negative prediction value was thus very strong. Since the follow-up of the participants of just over seven years is relatively short, we need to follow them longer in order to probably also get a stronger positive prediction value – that is, how great the probability is that a person will actually get a macrovascular event", says Sonia García-Calzón, researcher at the University of Navarre, Pamplona.
People with type 2 diabetes who are found to be at risk of developing cardiovascular disease can thus get quick help with preventive measures regarding diet, physical activity and weight management. They may also get more help to improve their blood sugar control and receive treatments that protect their heart and blood vessels.
"Healthcare today uses clinical variables such as age, gender, blood pressure, smoking, harmful cholesterol, long-term blood sugar and kidney function to estimate the risk of future cardiovascular disease, but it is a rather blunt tool. If you add DNA methylation, you have a much better measure of a future risk. We therefore want to develop a kit for clinical use, so that a simple blood sample can measure DNA methylation and predict who is at risk of becoming ill using the scoring scale", concludes Charlotte Ling.
Contact:
Charlotte Ling, Professor of Diabetes Research, especially Epigenetics at LUDC (Lund University's Diabetes Center) and the strategic research area Exodiab (Excellence of Diabetes Research in Sweden), Lund University. charlotte.ling@med.lu.se, Phone: +46 70-6145146.
Sonia García-Calzón, Associate Professor & Researcher at the Department of Food Science and Physiology and at the Center for Nutrition Research, University of Navarra, Pamplona. CIBEROBN, Instituto de Salud Carlos III. sgcalzon@unav.es
END
Biomarkers reveal risk of cardiovascular disease in type 2 diabetes
An international research team led from Lund University, has identified epigenetic biomarkers that can predict which people with type 2 diabetes are at risk of cardiovascular disease. The study is now published in Cell Reports Medicine.
2025-08-07
ELSE PRESS RELEASES FROM THIS DATE:
UVA harnesses AI to improve brain cancer care
2025-08-07
University of Virginia School of Medicine scientists are tapping the power of artificial intelligence to enhance and accelerate treatment for glioblastoma, the deadliest brain cancer.
UVA researcher Bijoy Kundu, PhD, and colleagues are developing an AI imaging approach to distinguish between tumor progression and brain changes caused by tumor treatment. It now can take months to make that distinction, leaving doctors uncertain if the tumor is growing and stalling important care decisions.
Kundu’s AI approach is already outperforming ...
MIT imaging tech promises deepest looks yet into living brain tissue at single-cell resolution
2025-08-07
Both for research and medical purposes, researchers have spent decades pushing the limits of microscopy to produce ever deeper and sharper images of brain activity, not only in the cortex but also in regions underneath such as the hippocampus. In a new study, a team of MIT scientists and engineers demonstrates a new microscope system capable of peering exceptionally deep into brain tissues to detect the molecular activity of individual cells by using sound.
“The major advance here is to enable us to image deeper at single-cell resolution,” ...
City of Hope Research Spotlight, July 2025
2025-08-07
LOS ANGELES — City of Hope® Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, life-threatening diseases. Each spotlight features research-related news, such as recognitions, collaborations and the latest research defining the future of medical treatment.
This roundup highlights two innovative clinical trials for promising cancer treatments, a potential liquid biopsy for gastric cancer, new insights into how to boost immune system ...
New experiment paves the way for secure, high-speed communication
2025-08-07
In a new paper published in Light: Science & Applications, a team of scientists from the Technical University of Denmark (DTU), the Austrian Institute of Technology (AIT), Fragmentix, University of Waterloo (UW), and Technische Universität Wien (TU) have successfully demonstrated a more practical and robust method for quantum key distribution, a breakthrough that could soon lead to more secure and cost-effective communication networks worldwide.
Imagine sharing secrets today that will stay safe – even from the most powerful quantum computers of tomorrow. That’s the promise of quantum key distribution (QKD), a method that uses the principles ...
Maple compound offers new way to fight tooth decay
2025-08-07
Washington, D.C. — A new study in the journal Microbiology Spectrum highlights the potential of using a natural compound from maple to combat the bacteria responsible for tooth decay: Streptococcus mutans. The compound, epicatechin gallate, is a powerful and safe alternative to traditional plaque-fighting agents. Its natural abundance, affordability and lack of toxicity make it especially promising for inclusion in oral care products such as mouthwashes, offering a safer option for young children, who often accidentally swallow mouthwash.
The new study emerged as an offshoot of research into natural compounds that ...
Novel immunologic surveillance study provides new insights into post-pandemic return of respiratory viruses
2025-08-07
AURORA, Colo. (Aug. 7, 2025) – The first paper from a multi-year clinical research study has been published in The Lancet Infectious Diseases: Dynamics of Endemic Virus Re-emergence in Children in the USA Following the COVID-19 Pandemic (2022-2023): A Longitudinal Immunoepidemiologic Surveillance Study and demonstrates how the approach can improve modeling to better predict future outbreaks.
The paper shares findings from a multicenter clinical research study, one of many studies that are part of the recently launched PREMISE (Pandemic Response Repository through Microbial and Immune Surveillance ...
New European guidelines reshape MASLD care with clearer diagnosis and targeted therapies
2025-08-07
A new framework for diagnosis
The 2024 European clinical practice guidelines introduce a pivotal terminology shift, replacing NAFLD (non-alcoholic fatty liver disease) with MASLD (metabolic dysfunction-associated steatotic liver disease) and NASH with MASH (metabolic dysfunction-associated steatohepatitis). This renaming is not just semantic—it provides a pathophysiologically grounded, inclusive classification system based on the presence of hepatic steatosis and at least one cardiometabolic risk factor.
Importantly, MASLD is now grouped ...
Adjuvant chemotherapy improves survival in resected early-onset pancreatic cancer after neoadjuvant therapy
2025-08-07
Background and objectives
The incidence of early-onset pancreatic cancer (EOPC) is rising, yet optimal treatment strategies remain unclear. While adjuvant chemotherapy (ACT) has shown survival benefits in pancreatic ductal adenocarcinoma, its specific role in EOPC patients following neoadjuvant chemotherapy (NACT) and surgery remains underexplored. This study aimed to assess the clinical benefit of ACT in EOPC patients after NACT.
Methods
This retrospective cohort study analyzed pancreatic ductal adenocarcinoma patients from the SEER database (2006–2019) who received NACT followed by curative resection. Propensity ...
Tech can tell exactly when in videos students are learning
2025-08-07
COLUMBUS, Ohio – A new study combines eye tracking and artificial intelligence to identify the exact moments in an educational video that matter for learning in children.
The study could also predict how much children understood from the video based on their eye movements while they were watching it.
The research is preliminary, but it provides promise for some exciting breakthroughs in video education, said Jason Coronel, lead author of the study and associate professor of communication at The Ohio State University.
“Our ultimate goal is to build ...
Quantum freezing at room temperature
2025-08-07
What are the limits of quantum physics? This is a question that has been researched around the world for decades. If we want to make the properties of the quantum world technically usable, we need to understand whether objects that are significantly larger than atoms and molecules can also exhibit quantum phenomena.
For example, small glass spheres with a diameter of one hundred nanometres can be examined – still over a thousand times smaller than a grain of sand, but huge by quantum standards. For years, attempts have been made to show the extent to which such spheres ...
LAST 30 PRESS RELEASES:
New scaffold technology helps combat traumatic brain injury by restoring copper balance
Bone metastases cultivate immature immune cells to resist immunotherapy
Liming can help enhance carbon capture in agricultural fields
National study urges expanded vaccine screening in emergency departments
Simple color-changing sensor quickly identifies poisonous gases
Exosomes found to play a double role in tumor growth and immune response
Announcing Gordian Biotechnology as Tier 5 Sponsor of ARDD 2025
Disconnection between brain regions explains why some people don’t enjoy music
An interstellar mission to a black hole? Astrophysicist thinks it’s possible.
Earth’s natural CO2 vacuum cleaners
It's not all about size
Cost-effectiveness of 2023-2024 COVID-19 vaccination in US adults
Demographics, lifestyle, comorbidities, prediabetes, and mortality
Climate change: Perito Moreno Glacier retreat has recently accelerated substantially
Population history of the Southern Caucasus
Biomarkers reveal risk of cardiovascular disease in type 2 diabetes
UVA harnesses AI to improve brain cancer care
MIT imaging tech promises deepest looks yet into living brain tissue at single-cell resolution
City of Hope Research Spotlight, July 2025
New experiment paves the way for secure, high-speed communication
Maple compound offers new way to fight tooth decay
Novel immunologic surveillance study provides new insights into post-pandemic return of respiratory viruses
New European guidelines reshape MASLD care with clearer diagnosis and targeted therapies
Adjuvant chemotherapy improves survival in resected early-onset pancreatic cancer after neoadjuvant therapy
Tech can tell exactly when in videos students are learning
Quantum freezing at room temperature
The first 25 years of SuperAger research
pH-responsive graphene-based nanocarriers: A breakthrough for cancer drug delivery
IBS in America: Despite advances, IBS remains a burden for many millions
Light up our love: Medaka courtship dynamics observed
[Press-News.org] Biomarkers reveal risk of cardiovascular disease in type 2 diabetesAn international research team led from Lund University, has identified epigenetic biomarkers that can predict which people with type 2 diabetes are at risk of cardiovascular disease. The study is now published in Cell Reports Medicine.